289 related articles for article (PubMed ID: 22895930)
1. Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease.
Herd CP; Tomlinson CL; Deane KH; Brady MC; Smith CH; Sackley CM; Clarke CE
Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD002812. PubMed ID: 22895930
[TBL] [Abstract][Full Text] [Related]
2. Speech and language therapy for dysarthria in Parkinson's disease.
Deane KH; Whurr R; Playford ED; Ben-Shlomo Y; Clarke CE
Cochrane Database Syst Rev; 2001; (2):CD002812. PubMed ID: 11406044
[TBL] [Abstract][Full Text] [Related]
3. Comparison of speech and language therapy techniques for speech problems in Parkinson's disease.
Herd CP; Tomlinson CL; Deane KH; Brady MC; Smith CH; Sackley CM; Clarke CE
Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD002814. PubMed ID: 22895931
[TBL] [Abstract][Full Text] [Related]
4. A comparison of speech and language therapy techniques for dysarthria in Parkinson's disease.
Deane KH; Whurr R; Playford ED; Ben-Shlomo Y; Clarke CE
Cochrane Database Syst Rev; 2001; (2):CD002814. PubMed ID: 11406045
[TBL] [Abstract][Full Text] [Related]
5. Occupational therapy for patients with Parkinson's disease.
Dixon L; Duncan D; Johnson P; Kirkby L; O'Connell H; Taylor H; Deane KH
Cochrane Database Syst Rev; 2007 Jul; 2007(3):CD002813. PubMed ID: 17636709
[TBL] [Abstract][Full Text] [Related]
6. A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson's disease: a study protocol for a randomised controlled trial.
Sackley CM; Rick C; Au P; Brady MC; Beaton G; Burton C; Caulfield M; Dickson S; Dowling F; Hughes M; Ives N; Jowett S; Masterson-Algar P; Nicoll A; Patel S; Smith CH; Woolley R; Clarke CE;
Trials; 2020 May; 21(1):436. PubMed ID: 32460885
[TBL] [Abstract][Full Text] [Related]
7. Occupational therapy for patients with Parkinson's disease.
Deane KH; Ellis-Hill C; Playford ED; Ben-Shlomo Y; Clarke CE
Cochrane Database Syst Rev; 2001; (3):CD002813. PubMed ID: 11687028
[TBL] [Abstract][Full Text] [Related]
8. Physiotherapy for patients with Parkinson's Disease: a comparison of techniques.
Deane KH; Jones D; Playford ED; Ben-Shlomo Y; Clarke CE
Cochrane Database Syst Rev; 2001; (3):CD002817. PubMed ID: 11687029
[TBL] [Abstract][Full Text] [Related]
9. A comparison of physiotherapy techniques for patients with Parkinson's disease.
Deane KH; Jones D; Ellis-Hill C; Clarke CE; Playford ED; Ben-Shlomo Y
Cochrane Database Syst Rev; 2001; (1):CD002815. PubMed ID: 11279765
[TBL] [Abstract][Full Text] [Related]
10. Non-pharmacological therapies for dysphagia in Parkinson's disease.
Deane KH; Whurr R; Clarke CE; Playford ED; Ben-Shlomo Y
Cochrane Database Syst Rev; 2001; 2001(1):CD002816. PubMed ID: 11279766
[TBL] [Abstract][Full Text] [Related]
11. Systematic review of paramedical therapies for Parkinson's disease.
Deane KH; Ellis-Hill C; Jones D; Whurr R; Ben-Shlomo Y; Playford ED; Clarke CE
Mov Disord; 2002 Sep; 17(5):984-91. PubMed ID: 12360547
[TBL] [Abstract][Full Text] [Related]
12. Lee Silverman Voice Treatment for dysarthria in patients with Parkinson's disease: a systematic review and meta-analysis.
Yuan F; Guo X; Wei X; Xie F; Zheng J; Huang Y; Huang Z; Chang Z; Li H; Guo Y; Chen J; Guo J; Tang B; Deng B; Wang Q
Eur J Neurol; 2020 Oct; 27(10):1957-1970. PubMed ID: 32539227
[TBL] [Abstract][Full Text] [Related]
13. Speech therapy for children with dysarthria acquired before three years of age.
Pennington L; Parker NK; Kelly H; Miller N
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD006937. PubMed ID: 27428115
[TBL] [Abstract][Full Text] [Related]
14. Speech and language therapy treatment on hypokinetic dysarthria in Parkinson disease: Systematic review and meta-analysis.
Muñoz-Vigueras N; Prados-Román E; Valenza MC; Granados-Santiago M; Cabrera-Martos I; Rodríguez-Torres J; Torres-Sánchez I
Clin Rehabil; 2021 May; 35(5):639-655. PubMed ID: 33233932
[TBL] [Abstract][Full Text] [Related]
15. Speech and language therapy for aphasia following stroke.
Brady MC; Kelly H; Godwin J; Enderby P; Campbell P
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD000425. PubMed ID: 27245310
[TBL] [Abstract][Full Text] [Related]
16. Physiotherapy versus placebo or no intervention in Parkinson's disease.
Tomlinson CL; Patel S; Meek C; Herd CP; Clarke CE; Stowe R; Shah L; Sackley CM; Deane KH; Wheatley K; Ives N
Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD002817. PubMed ID: 24018704
[TBL] [Abstract][Full Text] [Related]
17. Anticholinergics for symptomatic management of Parkinson's disease.
Katzenschlager R; Sampaio C; Costa J; Lees A
Cochrane Database Syst Rev; 2003; 2002(2):CD003735. PubMed ID: 12804486
[TBL] [Abstract][Full Text] [Related]
18. Speech and language therapy for aphasia following stroke.
Kelly H; Brady MC; Enderby P
Cochrane Database Syst Rev; 2010 May; (5):CD000425. PubMed ID: 20464716
[TBL] [Abstract][Full Text] [Related]
19. Speech therapy for children with dysarthria acquired before three years of age.
Pennington L; Miller N; Robson S
Cochrane Database Syst Rev; 2009 Oct; (4):CD006937. PubMed ID: 19821391
[TBL] [Abstract][Full Text] [Related]
20. Physiotherapy for Parkinson's disease: a comparison of techniques.
Tomlinson CL; Herd CP; Clarke CE; Meek C; Patel S; Stowe R; Deane KH; Shah L; Sackley CM; Wheatley K; Ives N
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD002815. PubMed ID: 24936965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
